The ratio of CD44-KD and CD147-KD tumor volumes (DTX/VC) decreased faster in response to DTX or VC treatment, suggesting that the KD of either CD44 or CD147 can induce suppression of tumor development, compared to the scr and wild-type xenografts. Here, CD44 is linked to neoplasm.